Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02923063 · ClinicalTrials.gov registry record · NA
Exercise Study Testing Enhanced Energetics of Mitochondria Video Integrated Delivery of Activity Training in CKD
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT02923063 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 32 participants.
The verdict
NCT02923063, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
Skeletal muscle dysfunction (sarcopenia) is an under-recognized target organ complication of CKD with substantial adverse clinical consequences of disability, hospitalization, and death. Sarcopenia in this proposal is defined by impaired metabolism and physical function associated with decreased skeletal muscle mass or function. Skeletal muscle tissue relies on mitochondria to efficiently utilize oxygen to generate ATP. Impaired mitochondrial energetics is a central mechanism of sarcopenia in CKD. The investigators propose a series of studies designed to shed light on the pathophysiology of sarcopenia in persons with CKD not treated with dialysis. Investigators will conduct a randomized-controlled intervention trial of combined resistance training and aerobic exercise vs. health education to assess changes in skeletal muscle mitochondrial function, metabolism and physical function. Investigators hypothesize that exercise improves mitochondrial function and physical function in persons with CKD. If successful, these experiments will identify novel pathophysiologic mechanisms for CKD-associated sarcopenia. The proposed study will provide useful insight into benefits associated with exercise among patients with CKD and investigate mechanisms associated with improved metabolism, muscle function and physical function in population.
Interventions
- BEHAVIORAL Combined Aerobic and Resistance Exercise via videoconferencing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2020-01-16 |
| Est. Completion | 2025-09-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02923063
The ClinicalTrials.gov registry entry for NCT02923063 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Combined Aerobic and Resistance Exercise via videoconferencing is the first listed.
NCT02923063 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02923063 about?
NCT02923063 is a clinical study titled "Exercise Study Testing Enhanced Energetics of Mitochondria Video Integrated Delivery of Activity Training in CKD". Skeletal muscle dysfunction (sarcopenia) is an under-recognized target organ complication of CKD with substantial adverse clinical consequences of disability, hospitalization, and death. Sarcopenia in this proposal is defined by impaired metabolism and physical function associated with decreased ske...
What is the current status of trial NCT02923063?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2020-01-16. Estimated completion is 2025-09-11.
What interventions are being tested in trial NCT02923063?
The interventions under investigation include: Combined Aerobic and Resistance Exercise via videoconferencing (BEHAVIORAL).
Who is sponsoring clinical trial NCT02923063?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.